September 13, 2018

Eli Lilly's New PET Scan Offers Another Tool for Studying Alzheimer's

Eli Lilly and Company and its wholly-owned subsidiary Avid Radiopharmaceuticalsannounced the successful Phase III trial of a Positron Emission Tomography (PET) imaging agent, flortaucipr F 18, in identifying tau in the brains of late-stage Alzheimer’s patients. {read more here}